Literature DB >> 22481033

Blister-like aneurysms of the internal carotid artery - management considerations.

N McLaughlin1, M Laroche, M W Bojanowski.   

Abstract

Blood blister-like aneurysms (BBA) originate at non-branching sites of the internal carotid artery (ICA). These aneurysms present a fragile wall and a poorly defined broad-based neck. Recognition of the BBA is essential for proper management of these vascular lesions. Various surgical and endovascular strategies have been attempted for these heterogeneous lesions. These have been associated with significant morbidity and mortality including rebleeding, regrowth, ischemic and thromboembolic complications. The authors review the key elements important for diagnosis and management of BBA and review current treatment options.
Copyright © 2012. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Year:  2012        PMID: 22481033     DOI: 10.1016/j.neuchi.2012.02.025

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  3 in total

Review 1.  Treatment of ruptured blood blister aneurysms using primary flow-diverter stenting with considerations for adjunctive coiling: A single-centre experience and literature review.

Authors:  Cunli Yang; Agnes Vadasz; István Szikora
Journal:  Interv Neuroradiol       Date:  2017-07-31       Impact factor: 1.610

Review 2.  Endovascular Treatment of Ruptured Blister-Like Aneurysms: A Systematic Review and Meta-Analysis with Focus on Deconstructive versus Reconstructive and Flow-Diverter Treatments.

Authors:  A Rouchaud; W Brinjikji; H J Cloft; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-17       Impact factor: 3.825

3.  Single-Cell RNA Sequencing Reveals the Pathogenic Relevance of Intracranial Atherosclerosis in Blood Blister-Like Aneurysms.

Authors:  Dingke Wen; Xing Wang; Ruiqi Chen; Hao Li; Jun Zheng; Wei Fu; Tianjie Zhang; Mu Yang; Chao You; Lu Ma
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.